Genmab, Merus file US antitrust paperwork
MLex Summary: Genmab and Merus filed paperwork with the US antitrust authorities on Oct. 28, according to a Merus filing with the US Securities and Exchange Commission. The waiting period under...To view the full article, register now.
Already a subscriber? Click here to view full article